# OnCo record ts-104 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ts-104/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ts-104" ;
  schema:name "TS-104"@en ;
  schema:description "TS-104 is an experimental peptide-drug conjugate from TwoStep Therapeutics, in phase 1 trials for non-small cell lung cancer, head and neck squamous cell carcinoma and endometrial cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/ts-104/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://twosteptx.com/twostep-therapeutics-announces-oversubscribed-62-5-million-series-a-financing-and-fda-clearance-of-ind-for-first-in-class-peptide-drug-conjugate/>, <https://twosteptx.com/twostep-therapeutics-announces-oversubscribed-62-5-million-series-a-financing-and-fda-clearance-of-ind-for-first-in-class-peptide-drug-conjugate/>, <https://twosteptx.com/science/>, <https://clinicaltrials.gov/api/v2/studies/NCT07814248>, <https://clinicaltrials.gov/search?intr=TS-104> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Peptide-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/esophageal/> ;
  onco:companies <https://onco.cc/companies/twostep-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07814248/> .